



Diversified Consumer Services | Small Cap
Nephro Care India Ltd, a key player in the Healthcare Services, showcases a mixed financial landscape. The company demonstrates strong profitability, driven by solid returns on capital, equity, and assets, coupled with healthy margins. Its growth trajectory is also impressive, marked by significant revenue and operating profit increases. However, certain areas raise concerns. Liquidity appears weak, and while solvency has improved recently, historical debt levels were high. Efficiency in utilizing assets is also a challenge. The company's earnings per share have declined. While interest coverage is strong, the absence of dividend coverage is noticeable. Overall, Nephro Care exhibits promising profitability and growth, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Nephro Care India Ltd, a key player in the Healthcare Services, showcases a mixed financial landscape. The company demonstrates strong profitability, driven by solid returns on capital, equity, and assets, coupled with healthy margins. Its growth trajectory is also impressive, marked by significant revenue and operating profit increases. However, certain areas raise concerns. Liquidity appears weak, and while solvency has improved recently, historical debt levels were high. Efficiency in utilizing assets is also a challenge. The company's earnings per share have declined. While interest coverage is strong, the absence of dividend coverage is noticeable. Overall, Nephro Care exhibits promising profitability and growth, but needs to address its liquidity and efficiency to ensure long-term financial stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
43.87
Industry Median
49.79
Small Cap Median
45.60
P/E RATIO
43.87
P/B RATIO
2.59
Industry Median
4.60
Small Cap Median
2.77
P/S RATIO
1.77
Industry Median
3.63
Small Cap Median
1.98
Others
PEG RATIO
0.00
EV/EBITDA RATIO
15.21
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹89.5 as on Aug 21, 2026.
The company exhibits strong growth in revenue and operating profit, indicating successful expansion and improved operational performance. However, the decline in earnings per share and net income growth rate raises concerns about profitability. The company is growing in terms of revenue, operating profit and asset but Earnings per share is declining which is not good.
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Vaidya Sane Ayurved Laboratories Ltd | 7.72 | 23.57 | Undervalued | 15.00 | 4.69 | 9.00 |
| 2 | Maitreya Medicare Ltd | 7.34 | -33.01 | Neutral | -0.46 | -1.96 | -2.47 |
| 3 | Lotus Eye Hospital & Institute Ltd | 6.07 | 328.53 | Overvalued | 3.38 | 0.04 | 0.08 |
| 4 | Nephro Care India Ltd | 5.69 | 43.87 | Neutral | 8.32 | 2.04 | 3.37 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
No Stock Reports Available at This Moment.
Nephro Care India Ltd is a comprehensive kidney care provider, specializing in dialysis services, nephrology consultations, and preventive renal care programs. Operating an integrated chain of centers primarily in Eastern India, it aims to deliver high-quality, accessible treatment for chronic kidney disease patients, establishing a significant market presence in specialized healthcare.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Nephro Care India Ltd's P/E ratio (TTM) is 43.87, compared to the industry median of 49.79 and large cap median of 45.60.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Nephro Care India Ltd's P/B ratio is 2.59, compared to the industry median of 4.60 and large cap median of 2.77.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Nephro Care India Ltd's P/S ratio is 1.77, compared to the industry median of 3.63 and large cap median of 1.98.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Nephro Care India Ltd's PEG ratio is N/A.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Nephro Care India Ltd's EV/EBITDA ratio is 15.21.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Nephro Care India Ltd's ROE is 5.93%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Nephro Care India Ltd's ROA is 11.44%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Nephro Care India Ltd's ROCE is 8.44%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Nephro Care India Ltd's operating margin is 9.38%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Nephro Care India Ltd's net margin is 3.80%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Nephro Care India Ltd's current ratio is 1.66.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Nephro Care India Ltd's debt-to-equity ratio is 0.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Nephro Care India Ltd's interest coverage ratio is 30.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Nephro Care India Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Nephro Care India Ltd's EPS is 2.04.
(Source line: "Ratios as of 22 Nov 2026, based on last traded price of ₹89.50. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2013
Headquarters: Kolkata, West Bengal
Core Offerings: Dialysis Services, Nephrology Consultations, Kidney Transplant Support, Renal Nutrition, Preventive Kidney Care
Stock Listing: NSE (NEPHROCARE), BSE ({bse})
Promoter: Dr. Sandip Kumar Sinha / Sandip Kumar Sinha Group
Nephro Care India Ltd was incorporated in 2013, focusing on providing specialized kidney care services. Over the years, it expanded its network of dialysis centers and nephrology clinics, particularly across Eastern India, establishing itself as an integrated renal care provider. The company emphasized comprehensive patient management, including consultations, dialysis, and preventive care. In 2024, it successfully undertook an Initial Public Offering (IPO) and listed on the NSE Emerge platform, marking a significant milestone in its growth journey.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Dialysis Services | Not Disclosed | Not Disclosed |
| Nephrology Consultations & Diagnostics | Not Disclosed | Not Disclosed |
| Preventive & Wellness Renal Care | Not Disclosed | Not Disclosed |
Dialysis Services: Operates an extensive network of dialysis centers offering hemodialysis and peritoneal dialysis for chronic kidney disease patients.
Nephrology Consultations & Diagnostics: Provides expert consultations by nephrologists, diagnostic services, and personalized treatment plans for various kidney ailments.
Preventive & Wellness Renal Care: Focuses on patient education, renal nutrition counseling, and wellness programs designed to manage and slow the progression of kidney disease.
Dr. Sandip Kumar Sinha (Chairman & Managing Director): A highly experienced and renowned nephrologist with over two decades of practice, he founded the company and is pivotal in its strategic direction and clinical excellence.
No major subsidiaries reported.
Initial Public Offering (IPO) on NSE Emerge in April 2024.
The Nephro Care India Ltd share price today is ₹89.50 on NSE (NEPHROCARE), as of 22 Nov 2026.
As of 22 Nov 2026, Nephro Care India Ltd share price is ₹89.50, with previous close ₹89.50. Today's range is ₹89.50 to ₹89.50. The 52-week range is ₹50.05 to ₹116.05.
As of today, Nephro Care India Ltd's market cap is ₹156.63 crore (Small Cap).
Nephro Care India Ltd's current P/E ratio is 43.87, compared to the DIVERSIFIED CONSUMER SERVICES sector average of 45.
Nephro Care India Ltd's current P/B ratio is 2.59.
Nephro Care India Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Nephro Care India Ltd's EPS (TTM) is ₹2.04.
Nephro Care India Ltd is a comprehensive kidney care provider, specializing in dialysis services, nephrology consultations, and preventive renal care programs. Operating an integrated chain of centers primarily in Eastern India, it aims to deliver high-quality, accessible treatment for chronic kidney disease patients, establishing a significant market presence in specialized healthcare.
Nephro Care India Ltd is promoted by Dr. Sandip Kumar Sinha / Sandip Kumar Sinha Group, holding 61.71% as of 22 Nov 2026.
Nephro Care India Ltd is listed on NSE (NEPHROCARE) and BSE ({bse}). Its next quarterly results are expected on Q1 FY25 (likely August 2024).